JP Morgan Chase
AUGX

JP Morgan Chase’s Augmedix, Inc. Common Stock AUGX Stock Holding History

JP Morgan Chase’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,573
Closed -$5.78K – 7763
2024
Q2 		$5.78K Sell
6,573
-42,658
-87% -$88K ﹤0.01% 6359
2024
Q1 		$201K Sell
49,231
-1,190
-2% -$5.32K ﹤0.01% 5350
2023
Q4 		$295K Buy
50,421
+47,616
+1,698% +$251K ﹤0.01% 5119
2023
Q3 		$14.4K Buy
+2,805
New +$13.2K ﹤0.01% 6158

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

JP Morgan Chase's AUGX Position: Q3 2024 in Review

JP Morgan Chase sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2024, closing a stake of 6,573 shares — an estimated $5.78K sold.

JP Morgan Chase first reported a position in AUGX in Q3 2023 and held it in 4 quarters. The position peaked at $295K in Q4 2023. 45 funds tracked by Wall St. Rank hold AUGX as of Q3 2024.

  • JP Morgan Chase reported no remaining Augmedix, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • JP Morgan Chase sold 6,573 Augmedix, Inc. Common Stock shares in Q3 2024, an estimated $5.78K.
  • JP Morgan Chase first reported a position in Augmedix, Inc. Common Stock in Q3 2023 and held it in 4 quarters.
  • JP Morgan Chase's Augmedix, Inc. Common Stock position peaked at $295K in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2024.

Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.